Kliniske studier for Astma i Kentucky
7 studier for Astma søker deltakere på steder i Kentucky.
Offisiell studietekst (engelsk)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Owensboro
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07645248A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Owensboro
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05757102Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Louisville
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Owensboro
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07301255A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Allergy & Asthma Specialists, P.S.C., Owensboro
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07219173A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Owensboro
RekruttererFase 2
Alder 4 til 11 · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07525375Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Louisville
- Research Site, Louisville
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT06307665Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.